APO Research
Talk to an analyst

APO RESEARCH · REPORT

Racemic Anisodamine Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Racemic Anisodamine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchRacemic Anisodamine Hydrochloride Injection Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Racemic Anisodamine Hydrochloride Injection Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Racemic Anisodamine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Racemic Anisodamine Hydrochloride Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Racemic Anisodamine Hydrochloride Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Racemic Anisodamine Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Racemic Anisodamine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Racemic Anisodamine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Racemic Anisodamine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Racemic Anisodamine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Racemic Anisodamine Hydrochloride Injection include Abbott, Tianjin Jinyao Pharmaceutical, Sichuan Medco Huakang Pharmaceutical, Shanghai Shangyao First Bio-pharmaceutical, Sanofi, Qilu Pharmaceutical, Jiangsu Wuzhong Pharmaceutical, Jiangsu Hengrui Medicine and North China Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Racemic Anisodamine Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Racemic Anisodamine Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Racemic Anisodamine Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Racemic Anisodamine Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Racemic Anisodamine Hydrochloride Injection Segment by Company

Abbott

Tianjin Jinyao Pharmaceutical

Sichuan Medco Huakang Pharmaceutical

Shanghai Shangyao First Bio-pharmaceutical

Sanofi

Qilu Pharmaceutical

Jiangsu Wuzhong Pharmaceutical

Jiangsu Hengrui Medicine

North China Pharmaceutical Group

Changjiang Pharmaceutical

Dalian Sky Pharmaceutical

Boehringer Ingelheim

Anyang Jiuzhou Pharmaceutical

Racemic Anisodamine Hydrochloride Injection Segment by Type

2ml:20mg

1ml:5mg

1ml:10mg

Racemic Anisodamine Hydrochloride Injection Segment by Application

Gastrointestinal Spasm

Urinary Spasm

Biliary Spasm

Racemic Anisodamine Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Racemic Anisodamine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Racemic Anisodamine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Racemic Anisodamine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Racemic Anisodamine Hydrochloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Racemic Anisodamine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Racemic Anisodamine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Racemic Anisodamine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Racemic Anisodamine Hydrochloride Injection Industry Trends Table 2. Racemic Anisodamine Hydrochloride Injection Industry Drivers Table 3. Racemic Anisodamine Hydrochloride Injection Industry Opportunities and Challenges Table 4. Racemic Anisodamine Hydrochloride Injection Industry Restraints Table 5. Global Racemic Anisodamine Hydrochloride Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Racemic Anisodamine Hydrochloride Injection Sales by Manufacturers (L) & (2021-2026) Table 8. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Manufacturers Table 9. Global Racemic Anisodamine Hydrochloride Injection Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global Racemic Anisodamine Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Racemic Anisodamine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Racemic Anisodamine Hydrochloride Injection Manufacturers, Product Type & Application Table 13. Global Racemic Anisodamine Hydrochloride Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Racemic Anisodamine Hydrochloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2ml:20mg Table 17. Major Manufacturers of 1ml:5mg Table 18. Major Manufacturers of 1ml:10mg Table 19. Global Racemic Anisodamine Hydrochloride Injection Sales by Type 2021 VS 2025 VS 2032 (L) Table 20. Global Racemic Anisodamine Hydrochloride Injection Sales by Type (2021-2026) & (L) Table 21. Global Racemic Anisodamine Hydrochloride Injection Sales by Type (2027-2032) & (L) Table 22. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Type (2021-2026) Table 23. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Type (2027-2032) Table 24. Global Racemic Anisodamine Hydrochloride Injection Revenue by Type 2021 VS 2025 VS 2032 (L) Table 25. Global Racemic Anisodamine Hydrochloride Injection Revenue by Type (2021-2026) & (L) Table 26. Global Racemic Anisodamine Hydrochloride Injection Revenue by Type (2027-2032) & (L) Table 27. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 28. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Gastrointestinal Spasm Table 30. Major Manufacturers of Urinary Spasm Table 31. Major Manufacturers of Biliary Spasm Table 32. Global Racemic Anisodamine Hydrochloride Injection Sales by Application 2021 VS 2025 VS 2032 (L) Table 33. Global Racemic Anisodamine Hydrochloride Injection Sales by Application (2021-2026) & (L) Table 34. Global Racemic Anisodamine Hydrochloride Injection Sales by Application (2027-2032) & (L) Table 35. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Application (2021-2026) Table 36. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Application (2027-2032) Table 37. Global Racemic Anisodamine Hydrochloride Injection Revenue by Application 2021 VS 2025 VS 2032 (L) Table 38. Global Racemic Anisodamine Hydrochloride Injection Revenue by Application (2021-2026) & (L) Table 39. Global Racemic Anisodamine Hydrochloride Injection Revenue by Application (2027-2032) & (L) Table 40. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 41. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 42. Global Racemic Anisodamine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 43. Global Racemic Anisodamine Hydrochloride Injection Sales by Region (2021-2026) & (L) Table 44. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 45. Global Racemic Anisodamine Hydrochloride Injection Sales Forecasted by Region (2027-2032) & (L) Table 46. Global Racemic Anisodamine Hydrochloride Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 48. North America Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 49. North America Racemic Anisodamine Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 50. Europe Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 51. Europe Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 52. Europe Racemic Anisodamine Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 53. Asia Pacific Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 54. Asia Pacific Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 55. Asia Pacific Racemic Anisodamine Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 56. South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 57. South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 58. South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 59. Global Racemic Anisodamine Hydrochloride Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Racemic Anisodamine Hydrochloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Racemic Anisodamine Hydrochloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Region (2021-2026) Table 63. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Region (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 68. Abbott Recent Development Table 69. Tianjin Jinyao Pharmaceutical Company Information Table 70. Tianjin Jinyao Pharmaceutical Business Overview Table 71. Tianjin Jinyao Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Tianjin Jinyao Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 73. Tianjin Jinyao Pharmaceutical Recent Development Table 74. Sichuan Medco Huakang Pharmaceutical Company Information Table 75. Sichuan Medco Huakang Pharmaceutical Business Overview Table 76. Sichuan Medco Huakang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sichuan Medco Huakang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 78. Sichuan Medco Huakang Pharmaceutical Recent Development Table 79. Shanghai Shangyao First Bio-pharmaceutical Company Information Table 80. Shanghai Shangyao First Bio-pharmaceutical Business Overview Table 81. Shanghai Shangyao First Bio-pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shanghai Shangyao First Bio-pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 83. Shanghai Shangyao First Bio-pharmaceutical Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sanofi Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 88. Sanofi Recent Development Table 89. Qilu Pharmaceutical Company Information Table 90. Qilu Pharmaceutical Business Overview Table 91. Qilu Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Qilu Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 93. Qilu Pharmaceutical Recent Development Table 94. Jiangsu Wuzhong Pharmaceutical Company Information Table 95. Jiangsu Wuzhong Pharmaceutical Business Overview Table 96. Jiangsu Wuzhong Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Jiangsu Wuzhong Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 98. Jiangsu Wuzhong Pharmaceutical Recent Development Table 99. Jiangsu Hengrui Medicine Company Information Table 100. Jiangsu Hengrui Medicine Business Overview Table 101. Jiangsu Hengrui Medicine Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Jiangsu Hengrui Medicine Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 103. Jiangsu Hengrui Medicine Recent Development Table 104. North China Pharmaceutical Group Company Information Table 105. North China Pharmaceutical Group Business Overview Table 106. North China Pharmaceutical Group Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. North China Pharmaceutical Group Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 108. North China Pharmaceutical Group Recent Development Table 109. Changjiang Pharmaceutical Company Information Table 110. Changjiang Pharmaceutical Business Overview Table 111. Changjiang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Changjiang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 113. Changjiang Pharmaceutical Recent Development Table 114. Dalian Sky Pharmaceutical Company Information Table 115. Dalian Sky Pharmaceutical Business Overview Table 116. Dalian Sky Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Dalian Sky Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 118. Dalian Sky Pharmaceutical Recent Development Table 119. Boehringer Ingelheim Company Information Table 120. Boehringer Ingelheim Business Overview Table 121. Boehringer Ingelheim Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Boehringer Ingelheim Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 123. Boehringer Ingelheim Recent Development Table 124. Anyang Jiuzhou Pharmaceutical Company Information Table 125. Anyang Jiuzhou Pharmaceutical Business Overview Table 126. Anyang Jiuzhou Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Anyang Jiuzhou Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio Table 128. Anyang Jiuzhou Pharmaceutical Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Racemic Anisodamine Hydrochloride Injection Distributors List Table 132. Racemic Anisodamine Hydrochloride Injection Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Racemic Anisodamine Hydrochloride Injection Product Image Figure 2. Global Racemic Anisodamine Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Racemic Anisodamine Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Racemic Anisodamine Hydrochloride Injection Sales (2021-2032) & (L) Figure 5. Global Racemic Anisodamine Hydrochloride Injection Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 Racemic Anisodamine Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2ml:20mg Image Figure 9. 1ml:5mg Image Figure 10. 1ml:10mg Image Figure 11. Global Racemic Anisodamine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 12. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Type (2021-2032) Figure 14. Global Racemic Anisodamine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 15. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 17. Gastrointestinal Spasm Image Figure 18. Urinary Spasm Image Figure 19. Biliary Spasm Image Figure 20. Global Racemic Anisodamine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 21. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Application (2021-2032) Figure 23. Global Racemic Anisodamine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 24. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 27. North America Racemic Anisodamine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 29. Canada Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 30. Mexico Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 31. Europe Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 32. Europe Racemic Anisodamine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 34. France Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 35. U.K. Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 36. Italy Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 37. Netherlands Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 38. Asia Pacific Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 39. Asia Pacific Racemic Anisodamine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 40. China Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 41. Japan Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 42. South Korea Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 43. Southeast Asia Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 44. India Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 45. Australia Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 46. South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 47. South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 49. South Africa Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 50. Saudi Arabia Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 51. Turkey Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 52. Argentina Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 53. UAE Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 54. Egypt Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 55. Chile Racemic Anisodamine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 56. Global Racemic Anisodamine Hydrochloride Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Racemic Anisodamine Hydrochloride Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Racemic Anisodamine Hydrochloride Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml:20mg
  • 1ml:5mg
  • 1ml:10mg
Applications
  • Gastrointestinal Spasm
  • Urinary Spasm
  • Biliary Spasm
Companies covered
  • Abbott
  • Tianjin Jinyao Pharmaceutical
  • Sichuan Medco Huakang Pharmaceutical
  • Shanghai Shangyao First Bio-pharmaceutical
  • Sanofi
  • Qilu Pharmaceutical
  • Jiangsu Wuzhong Pharmaceutical
  • Jiangsu Hengrui Medicine
  • North China Pharmaceutical Group
  • Changjiang Pharmaceutical
  • Dalian Sky Pharmaceutical
  • Boehringer Ingelheim
  • Anyang Jiuzhou Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Racemic Anisodamine Hydrochloride Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Racemic Anisodamine Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Racemic Anisodamine Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Racemic Anisodamine Hydrochloride Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Racemic Anisodamine Hydrochloride Injection Market Dynamics
  1. 2.1 Racemic Anisodamine Hydrochloride Injection Industry Trends
  2. 2.2 Racemic Anisodamine Hydrochloride Injection Industry Drivers
  3. 2.3 Racemic Anisodamine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Racemic Anisodamine Hydrochloride Injection Industry Restraints
3 Racemic Anisodamine Hydrochloride Injection Market by Manufacturers
  1. 3.1 Global Racemic Anisodamine Hydrochloride Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Racemic Anisodamine Hydrochloride Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Racemic Anisodamine Hydrochloride Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Racemic Anisodamine Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Racemic Anisodamine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Racemic Anisodamine Hydrochloride Injection Manufacturers, Product Type & Application
  7. 3.7 Global Racemic Anisodamine Hydrochloride Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Racemic Anisodamine Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Racemic Anisodamine Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Racemic Anisodamine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Racemic Anisodamine Hydrochloride Injection Market by Type
  1. 4.1 Racemic Anisodamine Hydrochloride Injection Type Introduction
  2. 4.1.1 2ml:20mg
  3. 4.1.2 1ml:5mg
  4. 4.1.3 1ml:10mg
  5. 4.2 Global Racemic Anisodamine Hydrochloride Injection Sales by Type
  6. 4.2.1 Global Racemic Anisodamine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Racemic Anisodamine Hydrochloride Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Racemic Anisodamine Hydrochloride Injection Revenue by Type
  10. 4.3.1 Global Racemic Anisodamine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Racemic Anisodamine Hydrochloride Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Type (2021-2032)
5 Racemic Anisodamine Hydrochloride Injection Market by Application
  1. 5.1 Racemic Anisodamine Hydrochloride Injection Application Introduction
  2. 5.1.1 Gastrointestinal Spasm
  3. 5.1.2 Urinary Spasm
  4. 5.1.3 Biliary Spasm
  5. 5.2 Global Racemic Anisodamine Hydrochloride Injection Sales by Application
  6. 5.2.1 Global Racemic Anisodamine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Racemic Anisodamine Hydrochloride Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Racemic Anisodamine Hydrochloride Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Racemic Anisodamine Hydrochloride Injection Revenue by Application
  10. 5.3.1 Global Racemic Anisodamine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Racemic Anisodamine Hydrochloride Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Application (2021-2032)
6 Global Racemic Anisodamine Hydrochloride Injection Sales by Region
  1. 6.1 Global Racemic Anisodamine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Racemic Anisodamine Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Racemic Anisodamine Hydrochloride Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Racemic Anisodamine Hydrochloride Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Racemic Anisodamine Hydrochloride Injection Revenue by Region
  1. 7.1 Global Racemic Anisodamine Hydrochloride Injection Revenue by Region
  2. 7.1.1 Global Racemic Anisodamine Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Racemic Anisodamine Hydrochloride Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Racemic Anisodamine Hydrochloride Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Racemic Anisodamine Hydrochloride Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032)
  8. 7.2.2 North America Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032)
  11. 7.3.2 Europe Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Racemic Anisodamine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Racemic Anisodamine Hydrochloride Injection Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Tianjin Jinyao Pharmaceutical
  8. 8.2.1 Tianjin Jinyao Pharmaceutical Company Information
  9. 8.2.2 Tianjin Jinyao Pharmaceutical Business Overview
  10. 8.2.3 Tianjin Jinyao Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Jinyao Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  12. 8.2.5 Tianjin Jinyao Pharmaceutical Recent Developments
  13. 8.3 Sichuan Medco Huakang Pharmaceutical
  14. 8.3.1 Sichuan Medco Huakang Pharmaceutical Company Information
  15. 8.3.2 Sichuan Medco Huakang Pharmaceutical Business Overview
  16. 8.3.3 Sichuan Medco Huakang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Medco Huakang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  18. 8.3.5 Sichuan Medco Huakang Pharmaceutical Recent Developments
  19. 8.4 Shanghai Shangyao First Bio-pharmaceutical
  20. 8.4.1 Shanghai Shangyao First Bio-pharmaceutical Company Information
  21. 8.4.2 Shanghai Shangyao First Bio-pharmaceutical Business Overview
  22. 8.4.3 Shanghai Shangyao First Bio-pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Shangyao First Bio-pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  24. 8.4.5 Shanghai Shangyao First Bio-pharmaceutical Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Racemic Anisodamine Hydrochloride Injection Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Qilu Pharmaceutical
  32. 8.6.1 Qilu Pharmaceutical Company Information
  33. 8.6.2 Qilu Pharmaceutical Business Overview
  34. 8.6.3 Qilu Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qilu Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  36. 8.6.5 Qilu Pharmaceutical Recent Developments
  37. 8.7 Jiangsu Wuzhong Pharmaceutical
  38. 8.7.1 Jiangsu Wuzhong Pharmaceutical Company Information
  39. 8.7.2 Jiangsu Wuzhong Pharmaceutical Business Overview
  40. 8.7.3 Jiangsu Wuzhong Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Wuzhong Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  42. 8.7.5 Jiangsu Wuzhong Pharmaceutical Recent Developments
  43. 8.8 Jiangsu Hengrui Medicine
  44. 8.8.1 Jiangsu Hengrui Medicine Company Information
  45. 8.8.2 Jiangsu Hengrui Medicine Business Overview
  46. 8.8.3 Jiangsu Hengrui Medicine Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Hengrui Medicine Racemic Anisodamine Hydrochloride Injection Product Portfolio
  48. 8.8.5 Jiangsu Hengrui Medicine Recent Developments
  49. 8.9 North China Pharmaceutical Group
  50. 8.9.1 North China Pharmaceutical Group Company Information
  51. 8.9.2 North China Pharmaceutical Group Business Overview
  52. 8.9.3 North China Pharmaceutical Group Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 North China Pharmaceutical Group Racemic Anisodamine Hydrochloride Injection Product Portfolio
  54. 8.9.5 North China Pharmaceutical Group Recent Developments
  55. 8.10 Changjiang Pharmaceutical
  56. 8.10.1 Changjiang Pharmaceutical Company Information
  57. 8.10.2 Changjiang Pharmaceutical Business Overview
  58. 8.10.3 Changjiang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Changjiang Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  60. 8.10.5 Changjiang Pharmaceutical Recent Developments
  61. 8.11 Dalian Sky Pharmaceutical
  62. 8.11.1 Dalian Sky Pharmaceutical Company Information
  63. 8.11.2 Dalian Sky Pharmaceutical Business Overview
  64. 8.11.3 Dalian Sky Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dalian Sky Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  66. 8.11.5 Dalian Sky Pharmaceutical Recent Developments
  67. 8.12 Boehringer Ingelheim
  68. 8.12.1 Boehringer Ingelheim Company Information
  69. 8.12.2 Boehringer Ingelheim Business Overview
  70. 8.12.3 Boehringer Ingelheim Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Boehringer Ingelheim Racemic Anisodamine Hydrochloride Injection Product Portfolio
  72. 8.12.5 Boehringer Ingelheim Recent Developments
  73. 8.13 Anyang Jiuzhou Pharmaceutical
  74. 8.13.1 Anyang Jiuzhou Pharmaceutical Company Information
  75. 8.13.2 Anyang Jiuzhou Pharmaceutical Business Overview
  76. 8.13.3 Anyang Jiuzhou Pharmaceutical Racemic Anisodamine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Anyang Jiuzhou Pharmaceutical Racemic Anisodamine Hydrochloride Injection Product Portfolio
  78. 8.13.5 Anyang Jiuzhou Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Racemic Anisodamine Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Racemic Anisodamine Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Racemic Anisodamine Hydrochloride Injection Production Mode & Process
  6. 9.2 Racemic Anisodamine Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Racemic Anisodamine Hydrochloride Injection Distributors
  9. 9.2.3 Racemic Anisodamine Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst